ID   CBTCi002-A
AC   CVCL_UL92
SY   EB3; EB3c9
DR   hPSCreg; CBTCi002-A
DR   Wikidata; Q93444603
RX   PubMed=31078962;
CC   From: Centro de Biotecnologia e Terapia Celular, Hospital Sao Rafael; Salvador; Brazil.
CC   Population: Afro-Brazilian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 8
//
RX   PubMed=31078962; DOI=10.1016/j.scr.2019.101454;
RA   Paredes, Bruno Diaz
RA   Martins, Gabriele Louise Soares
RA   Azevedo, Carine Machado
RA   Sampaio, Gabriela Louise Almeida
RA   Nonaka, Carolina Kymie Vasques
RA   da Silva, Katia Nunes
RA   Soares, Milena Botelho Pereira
RA   dos Santos, Ricardo Ribeiro
RA   de Freitas Souza, Bruno Solano
RT   "Generation of three control iPS cell lines for sickle cell disease
RT   studies by reprogramming erythroblasts from individuals without
RT   hemoglobinopathies.";
RL   Stem Cell Res. 38:101454-101454(2019).
//